Report Categories
View AllRecent Articles
View All
What downside volume Guardant Health GH 035 20260429
MKL Markel Group posts massive Q1 2026 EPS miss even as shares edge 039 percent higher in todays trading
ORIQ Origin CEO highlights planned portfolio diversification in comments accompanying latest quarterly earnings
SCEM SCE Trust releases latest quarterly earnings no core financial performance data disclosed to investors yet
AIRelated Layoffs as a Stock Catalyst The Market May Not Agree
Alibaba Unveils NextGeneration Zhenwu AI Chip and New Large Language Model
US Jobless Claims Remain Near Historic Lows in Latest Week
SoftBanks Ambitious AI Initiative Attracts Leading Japanese Manufacturers
On Holding Executives and Founder Increase Stake in Company
Indian Equities Conclude Week in Positive Territory Amidst USIran Diplomacy
Pineapple Financial Inc PAPL Q3 2025 Earnings Narrowing Losses Beat Expectations Yet Shares Slip
Rigetti Computing Inc RGTI Q1 2026 Earnings NarrowerThanExpected Loss as Quantum Computing Firm Prepares for Commercial Scale
PHAR Q1 2026 Earnings EPS Misses Estimates by Wide Margin
Redwood Trust Inc 9500 Senior Notes Due 2030 RWTQ Q1 2026 Earnings EPS Falls Short Amid Challenging Market Conditions
HIW Q1 2026 Earnings Massive EPS Surprise of 161 Drives Stock Rally
OTEX Q1 2026 Earnings EPS Surpasses Estimates by 75 Stock Declines
AirJoule Technologies AIRJ Surges 9 Key Support and Resistance Levels to Watch
Kratos Defense Security Solutions KTOS Shows Resilience with 110 Gain Testing Key Resistance Levels
Expedia Group EXPE Softens as Travel Sector Faces Headwinds Key Levels to Watch
First Internet Bancorp INBK Retreats Slightly as Stock Tests Nearby Support Levels
STRK Preferred Shares Edge Higher Consolidating Near Resistance
Modular Medical Inc MODD Q3 2025 Earnings EPS Miss Weighs Despite Positive Stock Reaction
Scholar Rock Q1 2026 Earnings WiderthanExpected Loss as Pipeline Development Continues
BIVI Q1 2026 Earnings EPS Beats Estimates Despite No Revenue Stock Drops
DTI Q1 2026 Earnings EPS Misses Expectations as Stock Declines
Atossa Therapeutics Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances